Federal award (PURCHASE ORDER, fiscal year 2022)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2023-05-31 to 2023-06-15
Current total value of award: $275.12
Description: 8509926410!HEPATITIS B VIRUS V